ABVC BioPharma, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
ABVC BioPharma, Inc. (ECOC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -8.70% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-08-12
- ABVC BioPharma, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2026-03-31 was -9.80%.
- ABVC BioPharma, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2025-03-31 was -1.10%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 6 month |
|---|---|---|
| 2026-06-30 | -8.70% 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -9.80% 10-Q · filed 2026-05-18 | |
| 2025-06-30 | -10.50% 10-Q · filed 2026-08-12 | |
| 2025-03-31 | -1.10% 10-Q · filed 2026-05-18 |